https://scholars.lib.ntu.edu.tw/handle/123456789/630068
標題: | Pembrolizumab or pembrolizumab plus chemotherapy versus standard of care chemotherapy in patients with advanced gastric or gastroesophageal junction adenocarcinoma: Asian subgroup analysis of KEYNOTE-062 | 作者: | Satake, Hironaga Lee, Keun-Wook Chung, Hyun Cheol Lee, Jeeyun Yamaguchi, Kensei Chen, Jen-Shi Yoshikawa, Takaki Amagai, Kenji KUN-HUEI YEH Goto, Masahiro Chao, Yee Lam, Ka-On Han, Shi Rong Shiratori, Shinichi Shah, Sukrut Shitara, Kohei |
關鍵字: | Asian patients; chemotherapy; gastric cancer; gastrooesophageal junction cancer; pembrolizumab | 公開日期: | 7-三月-2023 | 出版社: | OXFORD UNIV PRESS | 卷: | 53 | 期: | 3 | 起(迄)頁: | 221 | 來源出版物: | Japanese journal of clinical oncology | 摘要: | First-line pembrolizumab with/without chemotherapy versus chemotherapy was evaluated in programmed death ligand 1 combined positive score ≥1, locally advanced/unresectable or metastatic gastric cancer/gastrooesophageal junction cancer in the KEYNOTE-062 study. We present results for patients enrolled in Asia. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/630068 | ISSN: | 0368-2811 | DOI: | 10.1093/jjco/hyac188 |
顯示於: | 腫瘤醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。